Impaired diastolic function and elevated Nt-proBNP levels in type 1 diabetic patients without overt cardiovascular disease

Acta Diabetologica

Volumn 50, Issue 2, 2013, Pages 155-161

  Yazici, Dilek ^a,b   Yavuz, Dilek Gogas ^a   Toprak, Ahmet ^a   Deyneli, Oguzhan ^a   Akalin, Sema ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Marmara University Medical School ^*  (Turkey)

Author keywords

Carotid intima media thickness; Left ventricular diastolic dysfunction; Nt pro BNP; Type 1 diabetes mellitus

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; CARDIAC IMAGING; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING;

ADULT; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIASTOLE; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84880925142     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0235-z     Document Type: Article

References (45)

1. Galderisi M, Anderson KM, Wilson PW, Levy D (1991) Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68:85-89
2. Rodrigues B, McNeill J (1992) The diabetic heart: metabolic causes for the development of cardiomyopathy. Cardiovascular Res 26:13-922
3. Piccini J, Klein L, Gheorghiade M, Bonow RO (2004) New insights into diastolic heart failure: role of diabetes mellitus. Am J Med 116(5A):64S-75S
4. Fang ZY, Prins JB, Marwick TH (2004) Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543-567
5. Vakili BA, Okin PM, Devereux RB (2001) Prognostic implications of left ventricular hypertrophy. Am Heart J 141:334-341
6. Nagueh SF, Middleton KF, Kopelen HA, Zoghbi WA, Quinones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527-1533
7. Zarich SW, Arbuckle BE, Cohen LR, Roberts M, Nesto RW (1988) Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiograph. J Am Coll Cardiol 12:114-120
8. Fraser GE, Luke R, Thompson S, Smith H, Carter S, Sharpe N (1995) Comparison of echocardiographic variables between type I diabetics and normal controls. Am J Cardiol 75:141-145
9. Paillole C, Dahan M, Paycha F, Solal AC, Passa P, Gourgon R (1989) Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am J Cardiol 64:1010-1016
10. Grossmann G, Schmidt A, Hauner H, Göller V, Stauch M, Pfeiffer EF, Hombach V (1991) Diastolic ventricular function in type 1 diabetic patients: a study using Doppler echocardiography. Diabet Med 8:208-212
11. Illan F, Valdés-Chávarri M, Tebar J, García A, Pascual H, Soria F, Hernández A, Vicente T (1992) Anatomical and functional cardiac abnormalities in type I diabetes. Clin Investig 70:403-410
12. de Simone G, Mureddu GF, Vaccaro O, Greco R, Sacco M, Rivellese A, Contaldo F, Riccardi G (2000) Cardiac abnormalities in type 1 diabetes. Ital Heart J 1:493-499
13. Taskiran M, Rasmussen V, Rasmussen B, Fritz-Hansen T, Larsson HB, Jensen GB, Hilsted J (2004) Left ventricular dysfunction in normotensive Type 1 diabetic patients: the impact of autonomic neuropathy. Diabet Med 21:524-530
14. Airaksinen KE, Koistinen MJ, Ikäheimo MJ, Huikuri HV, Korhonen U, Pirttiaho H, Linnaluoto MK, Takkunen JT (1989) Augmentation of atrial contribution to left ventricular filling in IDDM subjects as assessed by Doppler echocardiography. Diabetes Care 12:159-161
15. Gul K, Celebi AS, Kacmaz F, Ozcan OC, Ustun I, Berker D, Aydin Y, Delibasi T, Guler S, Barazi AO (2009) Tissue Doppler imaging must be performed to detect early left ventricular dysfunction in patients with type 1 diabetes mellitus. Eur J Echocardiogr 10:841-846
16. Karamitsos TD, Karvounis HI, Didangelos T, Parcharidis GE, Karamitsos DT (2008) Impact of autonomic neuropathy on left ventricular function in normotensive type 1 diabetic patients: a tissue Doppler echocardiographic study. Diabetes Care 31:325-327
17. Di Cori A, Di Bello V, Miccoli R, Talini E, Palagi C, Delle Donne MG, Penno G, Nardi C, Bianchi C, Mariani M, Del Prato S, Balbarini A et al (2007) Left ventricular function in normotensive young adults with well-controlled type 1 diabetes mellitus. Am J Cardiol 99:84-90
18. Romanens M, Fankhauser S, Saner B, Michaud L, Saner H (1999) No evidence for systolic or diastolic left ventricular dysfunction at rest in selected patients with long-term type I diabetes mellitus. Eur J Heart Fail 1:169-175
19. Nakao K, Ogawa Y, Suga S, Imura H (1992) Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J Hypertens 10:907-912
20. Hino J, Tateyama H, Minamino N, Kangawa K, Matsuo H (1990) Isolation and identification of human brain natriuretic peptides in cardiac atrium. Biochem Biophys Res Commun 167:693-700
21. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M (1998) Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135:825-832
22. Krishnaswamy P, Lubien E, Clopton P, Koon J, Kazanegra R, Wanner E, Gardetto N, Garcia A, DeMaria A, Maisel AS (2001) Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 111:274-279
23. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105:595-601
24. Görmüş U, Ozmen D, Ozmen B, ParIldar Z, Ozdoǧan O, Mutaf I, Bayindir O (2009) Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction. Diabetes Res Clin Pract 87:51-56
25. Valle R, Bagolin E, Canali C, Giovinazzo P, Barro S, Aspromonte N, Carbonieri E, Milani L (2006) The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur J Echocardiogr 7:40-44
26. Salem M, El Behery S, Adly A, Khalil D, El Hadidi E (2009) Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 10:513-521
27. McKenna K, Smith D, Sherlock M, Moore K, O'Brien E, Tormey W, Thompson CJ (2005) Elevated plasma concentrations of atrial and brain natriuretic peptide in type 1 diabetic subjects. Ir J Med Sci 174:53-57
28. Bayerle-Eder M, Zangeneh M, Kreiner G, Raffesberg W, Nowotny P, Vierhapper H, Waldhäusl W, Wolzt M, Pleiner H, Gasic S (2003) ANP but not BNP reflects early left diastolic dysfunction in type 1 diabetics with myocardial dysinnervation. Horm Metab Res 35:301-307
29. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083
30. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458
31. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee On Quantitation Of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358-367
32. European Study Group on Diastolic Heart Failure (1998) How to diagnose diastolic heart failure. Eur Heart J 19:990-1003
33. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, Lee YW (1997) Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 30:474-480
34. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM et al (2000) Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation 102:1788-1794
35. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R (1988) Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 70:253-261
36. Garcia MJ, Thomas JD, Klein AL (1998) New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 32:865-875
37. Magnusson M, Melander O, Israelsson B, Grubb A, Groop L, Jovinge S (2004) Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease. Diabetes Care 27:1929-1935
38. Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H (2008) BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 10:252-259
39. Huelsmann M, Neuhold S, Strunk G, Moertl D, Berger R, Prager R, Abrahamian H, Riedl M, Pacher R, Luger A, Clodi M (2008) NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus. Eur Heart J 9:2259-2264
40. Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, Edelman S, Henry R, Maisel A (2003) Utility of B-type natriuretic peptide (BNP) as ascreen for left ventricular dysfunction in patients with diabetes. Diabetes Care 26:2081-2087
41. Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman SV, Maisel AS, Henry RR (2004) Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol 44:1047-1052
42. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E (2001) The prognostic value of B-type natriuretic peptide inpatients with acute coronary syndromes. N Engl J Med 345:1014-1021
43. Lim HS, Patel JV, Nadar S, Hughes EA, Lip GY (2005) Comparison of brain natriuretic peptide and left ventricular diastolic function determined by tissue Doppler inpatients with diabetes mellitus, patients with hypertension without diabetes, and in healthy subjects. Am J Cardiol 95:905-908
44. Eggers KM, Lindahl B, Venge P, Lind L (2009) B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years. Am J Cardiol 103:1032-1038
45. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88:82-91